Showing results (671-680 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|September 7, 2004
A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgeryJames M Bailey, Timothy M Hoffman, David L Wessel, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 7, 2004
A Bayesian approach to tracking patients having changing pharmacokinetic parametersDavid S Bayard, Roger W JelliffeJournal of Pharmacokinetics and Pharmacodynamics|November 3, 2004
Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepamIvelina I Gueorguieva, Ivan A Nestorov, Malcolm RowlandJournal of Pharmacokinetics and Pharmacodynamics|November 3, 2004
Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanismKristin K Isaacs, Marina V Evans, Thomas R HarrisJournal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolitesHisham A El-Masri, Elaina M KenyonJournal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO)Sukyung Woo, Wojciech Krzyzanski, William J JuskoJournal of Pharmacokinetics and Pharmacodynamics|June 6, 2006
Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptorsShashi B Bhatt, Anton Amann, Vladimir NigrovicJournal of Pharmacokinetics and Pharmacodynamics|November 22, 2008
Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery diseaseC Steven Ernest, David S Small, Shashank Rohatagi, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 26, 2009
A probabilistic approach for the evaluation of pharmacological effect induced by patient irregular drug intakeJun Li, Fahima NekkaJournal of Pharmacokinetics and Pharmacodynamics|February 10, 2009
Covariate-based dose individualization of the cytotoxic drug indisulam to reduce the risk of severe myelosuppressionAnthe S Zandvliet, Jan H M Schellens, William Copalu, et al.Pageof 107